Article
Low Dose Naltrexone Prescribing Practices for Children and Adolescents with Long COVID
2026-02-22
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> Pediatric long COVID is associated with substantial symptom burden, yet evidence-based pharmacologic treatments remain limited. Low-dose naltrexone (LDN) has been proposed as a potential symptomatic therapy, but data in pediatric populations is lacking. <h4>Methods</h4> We conducted a retrospective analysis of pediatric and young adult patients (≤25 years) with a clinical d...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ff451b50-5610-5942-aa1f-1960913a834c
- DOI
- 10.64898/2026.02.20.26346719
